ACT is pioneering a new class of implantable drug delivery technologies to selectively target tumor cells in borderline resectable or non-resectable tumors, with the simultaneous goals of sparing tissue, significantly enhancing treatment efficacy and reducing systemic side toxicity.
Drug Delivery System for Pancreatic Cancer — Open Surgical Procedures
Drug Delivery System for Pancreatic Cancer — Laparoscopic Surgical Placement + Indwelling Port
Drug Delivery System for Head and Neck Cancers
On-Board Tumor Microenvironment Monitoring for Iontophoretic Drug Delivery